Global Patent Index - EP 4103157 A1

EP 4103157 A1 20221221 - PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND METFORMIN

Title (en)

PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND METFORMIN

Title (de)

PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT LINAGLIPTIN UND METFORMIN

Title (fr)

COMPOSITION PHARMACEUTIQUE CONTENANT DE LA LINAGLIPTINE ET DE LA METFORMINE

Publication

EP 4103157 A1 20221221 (EN)

Application

EP 21705444 A 20210209

Priority

  • EP 20460012 A 20200213
  • EP 2021053072 W 20210209

Abstract (en)

[origin: WO2021160608A1] The present invention relates to a pharmaceutical composition comprising the combination of linagliptin and metformin as active ingredients.

IPC 8 full level

A61K 9/20 (2006.01); A61K 31/133 (2006.01); A61K 31/155 (2006.01); A61K 31/522 (2006.01)

CPC (source: EP)

A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2059 (2013.01); A61K 31/133 (2013.01); A61K 31/155 (2013.01); A61K 31/522 (2013.01)

C-Set (source: EP)

  1. A61K 31/155 + A61K 2300/00
  2. A61K 31/133 + A61K 2300/00
  3. A61K 31/522 + A61K 2300/00

Citation (search report)

See references of WO 2021160608A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2021160608 A1 20210819; CA 3170233 A1 20210819; EP 4103157 A1 20221221

DOCDB simple family (application)

EP 2021053072 W 20210209; CA 3170233 A 20210209; EP 21705444 A 20210209